RhumbLine Advisers’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.25B | Sell |
1,358,698
-30,862
| -2% | -$31.3M | 1.07% | 12 |
|
|
2025
Q4 | $1.49B | Sell |
1,389,560
-51,256
| -4% | -$49M | 1.21% | 11 |
|
|
2025
Q3 | $1.1B | Sell |
1,440,816
-24,238
| -2% | -$18M | 0.88% | 13 |
|
|
2025
Q2 | $1.14B | Sell |
1,465,054
-30,667
| -2% | -$23.8M | 0.98% | 13 |
|
|
2025
Q1 | $1.24B | Buy |
1,495,721
+6,932
| +0.5% | +$5.77M | 1.16% | 12 |
|
|
2024
Q4 | $1.15B | Sell |
1,488,789
-25,869
| -2% | -$21.4M | 1.03% | 12 |
|
|
2024
Q3 | $1.34B | Sell |
1,514,658
-64,744
| -4% | -$58.2M | 1.21% | 11 |
|
|
2024
Q2 | $1.43B | Buy |
1,579,402
+38,762
| +3% | +$31M | 1.34% | 8 |
|
|
2024
Q1 | $1.2B | Sell |
1,540,640
-27
| -0% | -$19.2K | 1.15% | 9 |
|
|
2023
Q4 | $898M | Sell |
1,540,667
-14,145
| -0.9% | -$8.26M | 0.94% | 13 |
|
|
2023
Q3 | $835M | Buy |
1,554,812
+9,618
| +0.6% | +$4.96M | 0.97% | 12 |
|
|
2023
Q2 | $725M | Buy |
1,545,194
+16,711
| +1% | +$7.01M | 0.81% | 15 |
|
|
2023
Q1 | $525M | Buy |
1,528,483
+58,471
| +4% | +$19.7M | 0.65% | 19 |
|
|
2022
Q4 | $538M | Buy |
1,470,012
+58,785
| +4% | +$20.8M | 0.72% | 18 |
|
|
2022
Q3 | $456M | Buy |
1,411,227
+28,492
| +2% | +$9.03M | 0.68% | 18 |
|
|
2022
Q2 | $448M | Buy |
1,382,735
+31,229
| +2% | +$9.37M | 0.65% | 20 |
|
|
2022
Q1 | $387M | Buy |
1,351,506
+20,139
| +2% | +$5.18M | 0.5% | 28 |
|
|
2021
Q4 | $368M | Buy |
1,331,367
+22,262
| +2% | +$5.64M | 0.45% | 33 |
|
|
2021
Q3 | $302M | Sell |
1,309,105
-37,477
| -3% | -$9.25M | 0.41% | 42 |
|
|
2021
Q2 | $309M | Sell |
1,346,582
-68,918
| -5% | -$13.8M | 0.41% | 41 |
|
|
2021
Q1 | $264M | Sell |
1,415,500
-95,984
| -6% | -$18.8M | 0.36% | 48 |
|
|
2020
Q4 | $255M | Sell |
1,511,484
-24,882
| -2% | -$3.72M | 0.35% | 51 |
|
|
2020
Q3 | $227M | Sell |
1,536,366
-14,780
| -1% | -$2.29M | 0.36% | 53 |
|
|
2020
Q2 | $255M | Buy |
1,551,146
+99,105
| +7% | +$15.2M | 0.43% | 40 |
|
|
2020
Q1 | $201M | Sell |
1,452,041
-15,011
| -1% | -$2.06M | 0.42% | 40 |
|
|
2019
Q4 | $193M | Sell |
1,467,052
-17,652
| -1% | -$2.05M | 0.32% | 58 |
|
|
2019
Q3 | $166M | Buy |
1,484,704
+28,867
| +2% | +$3.21M | 0.3% | 60 |
|
|
2019
Q2 | $161M | Sell |
1,455,837
-68,660
| -5% | -$8.09M | 0.3% | 60 |
|
|
2019
Q1 | $198M | Sell |
1,524,497
-14,146
| -0.9% | -$1.72M | 0.38% | 50 |
|
|
2018
Q4 | $178M | Buy |
1,538,643
+12,962
| +0.8% | +$1.45M | 0.39% | 43 |
|
|
2018
Q3 | $164M | Sell |
1,525,681
-32,180
| -2% | -$3.22M | 0.32% | 58 |
|
|
2018
Q2 | $133M | Buy |
1,557,861
+18,581
| +1% | +$1.53M | 0.27% | 68 |
|
|
2018
Q1 | $119M | Sell |
1,539,280
-37,509
| -2% | -$3.02M | 0.25% | 77 |
|
|
2017
Q4 | $133M | Buy |
1,576,789
+35,349
| +2% | +$3.01M | 0.27% | 70 |
|
|
2017
Q3 | $132M | Sell |
1,541,440
-58,424
| -4% | -$4.79M | 0.29% | 63 |
|
|
2017
Q2 | $132M | Buy |
1,599,864
+20,873
| +1% | +$1.7M | 0.3% | 61 |
|
|
2017
Q1 | $133M | Buy |
1,578,991
+79,286
| +5% | +$6.35M | 0.31% | 57 |
|
|
2016
Q4 | $110M | Buy |
1,499,705
+45,518
| +3% | +$3.39M | 0.28% | 64 |
|
|
2016
Q3 | $117M | Buy |
1,454,187
+54,401
| +4% | +$4.35M | 0.32% | 56 |
|
|
2016
Q2 | $110M | Buy |
1,399,786
+58,824
| +4% | +$4.43M | 0.33% | 56 |
|
|
2016
Q1 | $96.6M | Buy |
1,340,962
+39,340
| +3% | +$2.98M | 0.3% | 61 |
|
|
2015
Q4 | $110M | Sell |
1,301,622
-8,820
| -0.7% | -$732K | 0.35% | 51 |
|
|
2015
Q3 | $110M | Sell |
1,310,442
-293
| -0% | -$24.7K | 0.37% | 52 |
|
|
2015
Q2 | $109M | Sell |
1,310,735
-206,734
| -14% | -$15.8M | 0.35% | 53 |
|
|
2015
Q1 | $110M | Sell |
1,517,469
-18,026
| -1% | -$1.28M | 0.32% | 65 |
|
|
2014
Q4 | $106M | Sell |
1,535,495
-21,400
| -1% | -$1.44M | 0.31% | 68 |
|
|
2014
Q3 | $101M | Sell |
1,556,895
-17,544
| -1% | -$1.11M | 0.3% | 66 |
|
|
2014
Q2 | $97.9M | Sell |
1,574,439
-66,114
| -4% | -$3.94M | 0.29% | 75 |
|
|
2014
Q1 | $96.6M | Sell |
1,640,553
-31,384
| -2% | -$1.75M | 0.29% | 75 |
|
|
2013
Q4 | $85.3M | Sell |
1,671,937
-52,554
| -3% | -$2.63M | 0.25% | 84 |
|
|
2013
Q3 | $86.8M | Sell |
1,724,491
-28,302
| -2% | -$1.48M | 0.27% | 79 |
|
|
2013
Q2 | $86.1M | Buy |
+1,752,793
| New | +$95.4M | 0.28% | 75 |
|
Other funds holding LLY
VCM
VPM
RhumbLine Advisers's LLY Position: Q1 2026 in Review
RhumbLine Advisers reduced its Eli Lilly (LLY) stake by 2.2% in Q1 2026, selling an estimated $31.3M and leaving 1,358,698 shares worth $1.25B. The position accounts for 1.07% of the portfolio, ranked #12.
RhumbLine Advisers first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.49B in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- RhumbLine Advisers held 1,358,698 shares of Eli Lilly worth $1.25B as of Q1 2026.
- RhumbLine Advisers sold 30,862 Eli Lilly shares in Q1 2026, an estimated $31.3M.
- Eli Lilly made up 1.07% of RhumbLine Advisers's portfolio in Q1 2026, its #12 holding.
- RhumbLine Advisers first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
- RhumbLine Advisers's Eli Lilly position peaked at $1.49B in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.